Myriad Genetics Grows Women's Health Biz With Counsyl Acquisition

Myriad Genetics has signed an agreement to acquire reproductive- testing company Counsyl for $375m. The acquisition is Myriad's largest acquisition to date and entry into the reproductive testing market.

Myriad Genetics Inc. is growing its women's health portfolio by buying reproductive-testing company Counsyl Inc. for $375m. The acquisition is Myriad's largest acquisition to date and entry into the lucrative reproductive testing market.

Counsyl currently offers three products in the women's health market including Foresight, an expanded carrier screening test; Prelude, a non-invasive...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Deals

More from Business